Overview
Clinical Meaning
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) share overlapping GI symptoms but differ fundamentally in pathophysiology, diagnosis, and management.
AGPCNP
AGPCNP
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) share overlapping GI symptoms but differ fundamentally in pathophysiology, diagnosis, and management. IBS is a functional GI disorder characterized by chronic abdominal pain associated with altered bowel habits WITHOUT identifiable structural or biochemical abnormalities. It is a disorder of gut-brain interaction involving visceral hypersensitivity (lowered pain threshold to luminal distension), altered GI motility, and psychosocial factors. IBD (Crohn disease and ulcerative colitis) is an immune-mediated chronic inflammatory condition with identifiable mucosal damage, tissue destruction, and systemic inflammation. Key distinguishing features: IBS has NO alarm features (no weight loss, no GI bleeding, no nocturnal symptoms, no fever, no anemia, NORMAL inflammatory markers, NORMAL calprotectin); IBD has alarm features (weight loss, bloody stools, nocturnal diarrhea, fever, anemia, elevated CRP/ESR, elevated fecal calprotectin). Fecal calprotectin is the single most useful non-invasive test for distinguishing IBS from IBD: elevated in IBD (reflects neutrophilic intestinal inflammation), NORMAL in IBS. IBS is diagnosed by Rome IV criteria (clinical criteria — no specific diagnostic test), while IBD requires endoscopy with biopsy for definitive diagnosis. IBS prevalence is 10-15%...
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.